Barclays
ZEAL

Barclays’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Barclays’s Portfolio ZEAL Stock Details ZEAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,200
Closed -$138K – 7202
2017
Q3 		$138K Buy
+7,200
New +$136K ﹤0.01% 4704

Other funds holding ZEAL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

Barclays's ZEAL Position: Q4 2017 in Review

Barclays sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q4 2017, closing a stake of 7,200 shares — an estimated $138K sold.

Barclays first reported a position in ZEAL in Q3 2017 and held it in 1 quarter. The position peaked at $138K in Q3 2017. 12 funds tracked by Wall St. Rank hold ZEAL as of Q4 2017.

  • Barclays reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Barclays sold 7,200 Zealand Pharma A/S American Depositary Shares shares in Q4 2017, an estimated $138K.
  • Barclays first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 1 quarter.
  • Barclays's Zealand Pharma A/S American Depositary Shares position peaked at $138K in Q3 2017.
  • 12 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q4 2017.

Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.